Physiology of GIP(1-30)NH2 in Humans

Exclusion Criteria

• •Treatment with medication or dietary supplements that cannot be paused for 12 hours
• •More than 14 units of alcohol per week or abuse of narcotics
• •Established liver disease and/or plasma alanine aminotransferase (ALT) ≥3 × normal value and/or INR outside the normal range
• •Renal impairment (eGFR \<60 ml/min/1.73 m2)
• •Severe arteriosclerotic heart disease or severe heart failure (NYHA group III or IV)
• •Low blood count (haemoglobin \<8.3 mol/l)
• •Special diet or planned body weight change before the trial period
• •First-degree relatives with diabetes
• •Participation in other clinical experiments with medication
• •Any disease/condition that the investigators estimate disturbing for the participation in the experiment